These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 2122481
21. Protective effects of benidipine against myocardial damage following ischemia and reperfusion in the isolated perfused rat heart. Yao K, Karasawa A. Biol Pharm Bull; 1994 Apr; 17(4):517-21. PubMed ID: 8069260 [Abstract] [Full Text] [Related]
22. Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis. Jeremy JY, Mikhailidis DP, Dandona P. Eur J Pharmacol; 1985 Jan 02; 107(2):259-62. PubMed ID: 3884343 [Abstract] [Full Text] [Related]
23. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Matsuda K, Mathur RS, Duzic E, Halushka PV. Am J Physiol; 1993 Dec 02; 265(6 Pt 1):E928-34. PubMed ID: 8279549 [Abstract] [Full Text] [Related]
24. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D. Arzneimittelforschung; 1994 Nov 02; 44(11):1196-202. PubMed ID: 7848331 [Abstract] [Full Text] [Related]
31. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. Naka M, Mais DE, Morinelli TA, Hamanaka N, Oatis JE, Halushka PV. J Pharmacol Exp Ther; 1992 Aug 02; 262(2):632-7. PubMed ID: 1386885 [Abstract] [Full Text] [Related]
34. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets. Brace LD, Venton DL, Le Breton GC. Am J Physiol; 1985 Jul 02; 249(1 Pt 2):H8-13. PubMed ID: 2409821 [Abstract] [Full Text] [Related]
35. Augmented potentiation of renal vasoconstrictor responses by thromboxane A2 receptor stimulation in the alloxan-diabetic rat. Hodgson WC, King RG, Boura AL. J Pharm Pharmacol; 1990 Jun 02; 42(6):423-7. PubMed ID: 1979623 [Abstract] [Full Text] [Related]
36. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension. Mistry M, Nasjletti A. Hypertension; 1988 Jun 02; 11(6 Pt 2):758-62. PubMed ID: 3164706 [Abstract] [Full Text] [Related]
37. Activation of TxA2/PGH2 receptors and protein kinase C contribute to coronary dysfunction in superoxide treated rat hearts. Gupte SA, Okada T, Tateyama M, Ochi R. J Mol Cell Cardiol; 2000 Jun 02; 32(6):937-46. PubMed ID: 10888248 [Abstract] [Full Text] [Related]
38. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat. Tsao PS, Lefer AM. Res Commun Chem Pathol Pharmacol; 1990 Nov 02; 70(2):205-11. PubMed ID: 2148980 [Abstract] [Full Text] [Related]
39. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)]. Block HU, Heinroth I, Giessler C, Pönicke K, Mentz P, Zehl U, Rettkowski W, Dunemann A, Förster W. Biomed Biochim Acta; 1983 Nov 02; 42(2-3):283-99. PubMed ID: 6411078 [Abstract] [Full Text] [Related]